Novome Biotechnologies Raises $43.5 Million Series B Financing to Advance its Pipeline of…
Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living medicines for chronic diseases, announced the close of a $43.5 million Series B financing. The…
Read More...
Read More...